[go: up one dir, main page]

IL162868A0 - Depot medicament, carrier materials for depot medicaments, and method for the production thereof - Google Patents

Depot medicament, carrier materials for depot medicaments, and method for the production thereof

Info

Publication number
IL162868A0
IL162868A0 IL16286803A IL16286803A IL162868A0 IL 162868 A0 IL162868 A0 IL 162868A0 IL 16286803 A IL16286803 A IL 16286803A IL 16286803 A IL16286803 A IL 16286803A IL 162868 A0 IL162868 A0 IL 162868A0
Authority
IL
Israel
Prior art keywords
depot
carrier
carrier materials
medicament
medicaments
Prior art date
Application number
IL16286803A
Other languages
English (en)
Original Assignee
Stoess & Co Gelatine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stoess & Co Gelatine filed Critical Stoess & Co Gelatine
Publication of IL162868A0 publication Critical patent/IL162868A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593Polyesters, e.g. PLGA or polylactide-co-glycolide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Biological Treatment Of Waste Water (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Detergent Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL16286803A 2002-02-16 2003-01-24 Depot medicament, carrier materials for depot medicaments, and method for the production thereof IL162868A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10206517A DE10206517A1 (de) 2002-02-16 2002-02-16 Depotarzneimittel, Trägermaterialien für Depotarzneimittel und Verfahren zu deren Herstellung
PCT/EP2003/000725 WO2003068192A1 (de) 2002-02-16 2003-01-24 Depotarzneimittel, trägermaterialien für depotarzneimittel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
IL162868A0 true IL162868A0 (en) 2005-11-20

Family

ID=27674694

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16286803A IL162868A0 (en) 2002-02-16 2003-01-24 Depot medicament, carrier materials for depot medicaments, and method for the production thereof
IL162868A IL162868A (en) 2002-02-16 2004-07-05 Depot medicament, carrier materials for depot medicaments and method for the production thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL162868A IL162868A (en) 2002-02-16 2004-07-05 Depot medicament, carrier materials for depot medicaments and method for the production thereof

Country Status (17)

Country Link
EP (1) EP1474110B1 (xx)
AT (1) ATE369123T1 (xx)
AU (1) AU2003210181A1 (xx)
BR (1) BR0307675A (xx)
DE (2) DE10206517A1 (xx)
DK (1) DK1474110T3 (xx)
EA (1) EA006988B1 (xx)
ES (1) ES2289304T3 (xx)
HU (1) HUP0500119A3 (xx)
IL (2) IL162868A0 (xx)
MX (1) MXPA04006982A (xx)
NO (1) NO20043860L (xx)
NZ (1) NZ533103A (xx)
PL (1) PL371785A1 (xx)
PT (1) PT1474110E (xx)
WO (1) WO2003068192A1 (xx)
ZA (1) ZA200403979B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20060682A1 (it) * 2006-12-19 2008-06-20 Sicit Chemitech S P A Nuovi derivati polimerici biodegradabili
DE102007011606A1 (de) 2007-03-02 2008-09-04 Carl Freudenberg Kg Faser-Wirrgelege
WO2021146240A1 (en) 2020-01-13 2021-07-22 Cargill, Incorporated Turkey collagen hydrolysates and methods of making

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
WO1996028143A1 (de) * 1995-03-10 1996-09-19 Boehringer Mannheim Gmbh Polypeptid-enthaltende pharmazeutische darreichungsformen in form von mikropartikeln und verfahren zu deren herstellung
DE19813174A1 (de) * 1998-03-25 1999-05-27 Schering Ag Mikropartikel aus Polymeren und mindestens einer gerüstbildenden Komponente und ihre Herstellung und Verwendung in der Ultraschalldiagnostik und zur ultraschallinduzierten Wirkstofffreisetzung
KR100696407B1 (ko) * 1999-04-16 2007-03-19 더블유엠. 마쉬 라이스 유니버시티 폴리(프로필렌 푸마레이트)-디아크릴레이트 마크로머와가교결합된 생분해성 폴리(프로필렌 푸마레이트) 네트워크

Also Published As

Publication number Publication date
EA006988B1 (ru) 2006-06-30
PL371785A1 (en) 2005-06-27
PT1474110E (pt) 2007-10-01
MXPA04006982A (es) 2004-11-10
HUP0500119A2 (hu) 2005-07-28
WO2003068192A1 (de) 2003-08-21
EP1474110A1 (de) 2004-11-10
HUP0500119A3 (en) 2008-04-28
EA200401012A1 (ru) 2005-04-28
NO20043860L (no) 2004-09-15
DE10206517A1 (de) 2003-09-04
DE50307874D1 (de) 2007-09-20
ATE369123T1 (de) 2007-08-15
ES2289304T3 (es) 2008-02-01
BR0307675A (pt) 2005-01-11
NZ533103A (en) 2007-04-27
DK1474110T3 (da) 2007-12-10
AU2003210181A1 (en) 2003-09-04
EP1474110B1 (de) 2007-08-08
IL162868A (en) 2008-03-20
ZA200403979B (en) 2004-11-29

Similar Documents

Publication Publication Date Title
GB2409662A (en) Method of production of composite materials
DE60018600D1 (de) Bioaktiver abbaubarer verbundstoff für "tissue engineering"
AU2586201A (en) Recycling of articles comprising hydroxy-phenoxyether polymers
MXPA04006545A (es) Nuevas formas de dosificacion farmaceutica y metodo para producir las mismas.
DE60214012D1 (de) Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung
DE602006014692D1 (de) Film mit reinigungsmittel
DE69426196D1 (de) Verfahren zur herstellung eines biologisch abbaubaren materials für die verzögerte freisetzung eines medikaments und dat so hergestellte material
BRPI0505635A (pt) artigo moldado de poliuretano e método de produção do mesmo
WO2001028591A3 (en) Injection vehicle for polymer-based formulations
WO2004100857A3 (en) Highly plastic granules for making fast melting tablets
SG160321A1 (en) Smoking articles and smokable filler material therefor
CA2476622A1 (en) A transdermal patch
MXPA03003473A (es) Metodos para producir compuestos de oxazolidinona.
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
DE50206912D1 (de) Verfahren zur kontinuierlichen herstellung und beschichtung von selbstklebemassen auf basis von sbc mit mindestens einem pharmazeutischen wirkstoff
EP1469886B8 (en) Lyophilized pharmaceutical composition of propofol
UA87700C2 (ru) Герметик для упаковки стекла и способ его изготовления
IL162868A0 (en) Depot medicament, carrier materials for depot medicaments, and method for the production thereof
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
IL155446A0 (en) Polycarbonate composite material which can be thermoplastically shaped, methods for the production thereof, use of the same and a flame-proof polycarbonate moulded part
TW200706597A (en) Dielectric material
ES2065688T3 (es) Contenedor y procedimiento para su fabricacion.
GR3034617T3 (en) Composite with sodium starch glycolate as a support material and products thereof
SG153663A1 (en) Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports
ATE411051T1 (de) Polypeptid, dessen konjugat doxorubicin enthält, und auf diesem basierende pharmazeutische zusammensetzung

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed